Abstract
The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol [1]. This development process to produce guidance, advice and recommendations for practice has National Institute for Health and Care Excellence (NICE) accreditation.
| Original language | English |
|---|---|
| Pages (from-to) | 2122-2127 |
| Number of pages | 6 |
| Journal | Rheumatology |
| Volume | 60 |
| Issue number | 5 |
| Early online date | 2 Feb 2021 |
| DOIs | |
| Publication status | Published - 14 May 2021 |
Bibliographical note
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].Keywords
- Antirheumatic Agents/therapeutic use
- Humans
- Rheumatology/standards
- Sjogren's Syndrome/drug therapy
Fingerprint
Dive into the research topics of 'The management of Sjögren's syndrome: British Society for Rheumatology guideline scope'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver